Valeant's stock plummets amid accusations of fraud

Heard on the Street's Miriam Gottfried and Alex Frangos are joined by Charlie Grant, who sheds light on why the Valeant Pharmaceuticals stock plummeted. Plus, more on the allegations that claim the company has been using a specialty pharmacy to manipulate it's revenue.